Similarly, advanced BC patients using single-agent paclitaxel or docetaxel led to an enhancement of NK and LAK cytotoxic activity and increase of IFN-γ, IL-2, IL-6, GM-CSF cytokine levels in serum (74, 75). The gene discussed is IFNG; the disease is breast cancer.